Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)

Clinical trial NCT00034853 · COMPLETED

Trial details

NCT number: NCT00034853
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Juvenile Rheumatoid

Start date: 2000-12-01
Primary completion: 2003-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.